India, Aug. 8 -- It has been established that there is a major public health problem in India with a population of more than 1.4 billion. Access to inexpensive medication constitutes a great difficulty. An increase in medication costs affects the bills of families in low- and middle-income countries. Today, 60% of people in India are unable to get timely access to such essential drugs, and nearly all health care leads to a self-paid out-of-pocket expenditure, while only 15% are insured, thus contributing to the expense.
Generic medicines have a therapeutic equivalence with their trademarked counterparts and conform to bioequivalence standards. Depending upon the therapeutic areas, they give maximum savings on existing branded counterpart...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.